vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Concentra Group Holdings Parent, Inc. (CON). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $539.1M, roughly 1.8× Concentra Group Holdings Parent, Inc.). Concentra Group Holdings Parent, Inc. runs the higher net margin — 6.4% vs 0.7%, a 5.7% gap on every dollar of revenue. Concentra Group Holdings Parent, Inc. produced more free cash flow last quarter ($98.5M vs $-6.0M).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Concentra Inc., is a national health care establishment centered around occupational health. It was founded in 1979 in Amarillo, Texas, and the headquarters of the corporation is in Addison, Texas. It runs 627 occupational health centers and 410 onsite health clinics at employer worksites across 47 states. According to the Bureau of Labor Statistics, Concentra treats one out of every seven occupational injuries in the United States. It is currently a publicly traded company with over 80% of t...

ASTH vs CON — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.8× larger
ASTH
$950.5M
$539.1M
CON
Higher net margin
CON
CON
5.7% more per $
CON
6.4%
0.7%
ASTH
More free cash flow
CON
CON
$104.5M more FCF
CON
$98.5M
$-6.0M
ASTH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTH
ASTH
CON
CON
Revenue
$950.5M
$539.1M
Net Profit
$6.6M
$34.7M
Gross Margin
Operating Margin
1.9%
12.9%
Net Margin
0.7%
6.4%
Revenue YoY
42.9%
Net Profit YoY
184.4%
EPS (diluted)
$0.12
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
CON
CON
Q4 25
$950.5M
$539.1M
Q3 25
$956.0M
$572.8M
Q2 25
$654.8M
$550.8M
Q1 25
$620.4M
$500.8M
Q4 24
$665.2M
Q3 24
$478.7M
$489.6M
Q2 24
$486.3M
$477.9M
Q1 24
$404.4M
Net Profit
ASTH
ASTH
CON
CON
Q4 25
$6.6M
$34.7M
Q3 25
$373.0K
$48.3M
Q2 25
$9.4M
$44.6M
Q1 25
$6.7M
$38.9M
Q4 24
$-7.8M
Q3 24
$16.1M
$44.3M
Q2 24
$19.2M
$51.7M
Q1 24
$14.8M
Operating Margin
ASTH
ASTH
CON
CON
Q4 25
1.9%
12.9%
Q3 25
2.0%
16.5%
Q2 25
3.1%
16.3%
Q1 25
3.3%
16.0%
Q4 24
0.1%
Q3 24
5.9%
17.6%
Q2 24
6.2%
17.6%
Q1 24
7.5%
Net Margin
ASTH
ASTH
CON
CON
Q4 25
0.7%
6.4%
Q3 25
0.0%
8.4%
Q2 25
1.4%
8.1%
Q1 25
1.1%
7.8%
Q4 24
-1.2%
Q3 24
3.4%
9.1%
Q2 24
3.9%
10.8%
Q1 24
3.7%
EPS (diluted)
ASTH
ASTH
CON
CON
Q4 25
$0.12
$0.27
Q3 25
$0.01
$0.38
Q2 25
$0.19
$0.35
Q1 25
$0.14
$0.30
Q4 24
$-0.14
Q3 24
$0.33
$0.37
Q2 24
$0.40
$0.50
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
CON
CON
Cash + ST InvestmentsLiquidity on hand
$429.5M
$79.9M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$779.3M
$393.3M
Total Assets
$2.2B
$2.9B
Debt / EquityLower = less leverage
3.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
CON
CON
Q4 25
$429.5M
$79.9M
Q3 25
$463.4M
$49.9M
Q2 25
$342.1M
$73.9M
Q1 25
$260.9M
$52.1M
Q4 24
$290.8M
Q3 24
$350.3M
$136.8M
Q2 24
$327.7M
$50.7M
Q1 24
$337.3M
Total Debt
ASTH
ASTH
CON
CON
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
Q3 24
$1.5B
Q2 24
$3.0M
Q1 24
Stockholders' Equity
ASTH
ASTH
CON
CON
Q4 25
$779.3M
$393.3M
Q3 25
$775.5M
$385.5M
Q2 25
$765.5M
$342.6M
Q1 25
$745.4M
$307.1M
Q4 24
$712.7M
Q3 24
$704.6M
$277.8M
Q2 24
$678.9M
$1.2B
Q1 24
$653.5M
Total Assets
ASTH
ASTH
CON
CON
Q4 25
$2.2B
$2.9B
Q3 25
$2.2B
$2.8B
Q2 25
$1.4B
$2.8B
Q1 25
$1.3B
$2.7B
Q4 24
$1.4B
Q3 24
$1.3B
$2.5B
Q2 24
$1.3B
$2.4B
Q1 24
$1.2B
Debt / Equity
ASTH
ASTH
CON
CON
Q4 25
3.98×
Q3 25
4.15×
Q2 25
4.82×
Q1 25
5.27×
Q4 24
Q3 24
5.30×
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
CON
CON
Operating Cash FlowLast quarter
$-2.9M
$118.7M
Free Cash FlowOCF − Capex
$-6.0M
$98.5M
FCF MarginFCF / Revenue
-0.6%
18.3%
Capex IntensityCapex / Revenue
0.3%
3.7%
Cash ConversionOCF / Net Profit
-0.44×
3.42×
TTM Free Cash FlowTrailing 4 quarters
$104.5M
$197.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
CON
CON
Q4 25
$-2.9M
$118.7M
Q3 25
$10.0M
$60.6M
Q2 25
$90.9M
$88.4M
Q1 25
$16.6M
$11.7M
Q4 24
$-10.9M
Q3 24
$34.0M
$65.9M
Q2 24
$23.2M
Q1 24
$6.0M
Free Cash Flow
ASTH
ASTH
CON
CON
Q4 25
$-6.0M
$98.5M
Q3 25
$7.4M
$39.4M
Q2 25
$89.5M
$63.2M
Q1 25
$13.6M
$-4.0M
Q4 24
$-13.5M
Q3 24
$31.7M
$50.8M
Q2 24
$20.4M
Q1 24
$5.6M
FCF Margin
ASTH
ASTH
CON
CON
Q4 25
-0.6%
18.3%
Q3 25
0.8%
6.9%
Q2 25
13.7%
11.5%
Q1 25
2.2%
-0.8%
Q4 24
-2.0%
Q3 24
6.6%
10.4%
Q2 24
4.2%
Q1 24
1.4%
Capex Intensity
ASTH
ASTH
CON
CON
Q4 25
0.3%
3.7%
Q3 25
0.3%
3.7%
Q2 25
0.2%
4.6%
Q1 25
0.5%
3.1%
Q4 24
0.4%
Q3 24
0.5%
3.1%
Q2 24
0.6%
Q1 24
0.1%
Cash Conversion
ASTH
ASTH
CON
CON
Q4 25
-0.44×
3.42×
Q3 25
26.69×
1.26×
Q2 25
9.65×
1.98×
Q1 25
2.48×
0.30×
Q4 24
Q3 24
2.11×
1.49×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

CON
CON

Occupational Health Center Workers Compensation$328.5M61%
Occupational Health Center Employer Services$151.9M28%
Onsite Health Clinics$36.2M7%
Other Businesses$12.3M2%
Occupational Health Center Consumer Health$8.1M2%
Occupational Health Center Other$2.1M0%

Related Comparisons